Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
JelikaLite logo — Developing an intelligent medical device for children on the...

JelikaLite

Developing an intelligent medical device for children on the autism spectrum

Founded 2019 United States New York, United States 6 employees Total: $408.67K Health Care, Medical Devices

General Information

Company Name JelikaLite
Founded Year 2019
Location United States New York, United States
Employees 6
Industries Health Care, Medical Devices
Social

BounceWatch is an independent company data service, not affiliated with JelikaLite. To contact JelikaLite, visit jelikalite.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does JelikaLite compare?

A PDF of JelikaLite and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting JelikaLite soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About JelikaLite

JelikaLite is a healthcare startup founded in 2019 with the aim of developing an intelligent medical device for children on the autism spectrum. The company's slogan, "Developing an intelligent medical device for children on the autism spectrum," encapsulates its commitment to addressing the needs of a growing population. JelikaLite's innovative product, Cognilum, is designed to provide an integrative solution with a focus on pediatric neurological health through non-invasive novel therapies. The company recognizes the lifelong impact of autism and the increasing rates of the condition. As such, JelikaLite is dedicated to providing a solution that enables children to integrate into society, empowers parents with a personalized and cost-effective home-based treatment, allows therapists to track progress and efficacy of interventions, and reduces the financial burden on payors and the government for special education and lifelong residential care. The latest funding round on 23 January 2023 was secured from Mount Sinai Innovation Partners, signaling confidence in JelikaLite's vision and product. The investment will likely further the development and commercialization of Cognilum, potentially providing substantial benefits for both the target population and society at large. JelikaLite's commitment to addressing a pressing societal need while offering potential returns for investors makes it a compelling prospect for venture capital funding.

Business keywords: Autism, Pediatric neurology, Intelligent medical device, Non-invasive therapies, Special education, Neurological disorders, Children's health, Therapeutic interventions, Home-based treatment, Therapist tracking, Cost-effective healthcare, Quality of life, Healthcare innovation

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Funding Round Undisclosed 1
Mount Sinai Innovation Partners
23 Jan 2023
Seed Round Undisclosed 2
Bioverge Ventures
Bioverge Ventures, New York Ventures
21 Dec 2022
Grant $256.00K 1
National Science Foundation
National Science Foundation
27 Apr 2022
Equity Crowdfunding $152.67K -
27 Dec 2021

JelikaLite Alternatives & Competitors

JelikaLite vs
Fractyl Health
Fractyl Health United States

Dedicated to novel therapies that can sustain long term weight management.

Series F
104 employees
Biotechnology, Health Care
JelikaLite vs
Neuronetics, Inc.
Neuronetics, Inc. United States

Non-drug, safe, effective treatment for depression and other mental health conditions.

Post-IPO Debt
220 employees
Biotechnology, Health Care
JelikaLite vs
Orasi Medical
Orasi Medical United States

Orasi Medical develops products to measure the effect of neurological treatments and track the progr...

Venture round
3 employees
Health Care, Medical Devices

FAQ About JelikaLite

Developing an intelligent medical device for children on the autism spectrum
JelikaLite was founded in 2019.
JelikaLite is headquartered in New York, United States.
JelikaLite operates in Health Care and Medical Devices. Its work centres on Autism, Pediatric neurology, Intelligent medical device and Non-invasive therapies.
JelikaLite has approximately 6 employees.
JelikaLite has completed 4 funding rounds, raising a total of $408.67K.
Top alternatives and competitors to JelikaLite include Fractyl Health, Neuronetics, Inc., Orasi Medical, Tesla Medical s.r.o., Boston Scientific. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
JelikaLite and Fractyl Health are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for JelikaLite, https://bouncewatch.com/company/jelikalite, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes